(Q34810831)

4 August 2017

title

Optimal use of sentinel lymph node biopsy versus axillary lymph node dissection in patients with breast carcinoma: a decision analysis (English)

1 reference

4 August 2017

0 references

1 reference

1 reference

5

Kelly M McMasters

1 reference

4 August 2017

Sandra L Wong

1

1 reference

4 August 2017

Troy D Abell

series ordinal

2

1 reference

4 August 2017

Celia Chao

series ordinal

3

1 reference

4 August 2017

Michael J Edwards

series ordinal

4

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

95

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

478-487

1 reference

Indications for axillary dissection in T1 breast cancer

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Axillary lymph node dissection for breast cancer: a decision analysis of T1 lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Anaphylaxis during breast cancer lymphatic mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Assessment of morbidity from complete axillary dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Reliability of sentinel lymph node biopsy for staging melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Axillary lymph nodes and breast cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

The role of sentinel lymph node biopsy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Sentinel lymph node mapping opens a new perspective in the surgical management of early-stage breast cancer: a combined approach with vital blue dye lymphatic mapping and radioguided surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Quality of life of breast cancer patients with lymphedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Guidelines for the Safe Use of Radioactive Materials During Localization and Resection of the Sentinel Lymph Node

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Learning sentinel node biopsy: results of a prospective randomized trial of two techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

The impact of prophylactic axillary node dissection on breast cancer survival--a Bayesian meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

A decision analysis of the effect of avoiding axillary lymph node dissection in low risk women with invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

Complications of level I and II axillary dissection in the treatment of carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

Impact of axillary lymph node dissection on the therapy of breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

Incidence of breast carcinoma-related lymphedema

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

Lymphedema after sentinel lymphadenectomy for breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

Patterns of axillary lymph node metastasis in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

Patient preferences for axillary dissection in the management of early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

Sentinel node biopsy in breast cancer: ALMANAC trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

Assessment of axillary lymph node status

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

Radiation safety with breast sentinel node biopsy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10696

7 January 2021

Identifiers

DOI

10.1002/CNCR.10696

1 reference

4 August 2017

1 reference